HL089297/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	4
2009	9
2010	6
2011	7
2012	4
2013	1
2014	3
2015	1
2019	1
2020	1
2021	1
2022	1
2024	0

1

Phosphodiesterases and cardiac cGMP: evolving roles and controversies.

Zhang M, Kass DA. Zhang M, et al. Trends Pharmacol Sci. 2011 Jun;32(6):360-5. doi: 10.1016/j.tips.2011.02.019. Epub 2011 Apr 7. Trends Pharmacol Sci. 2011. PMID: 21477871 Free PMC article. Review.

2

Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials.

Kass DA. Kass DA. Curr Heart Fail Rep. 2012 Sep;9(3):192-9. doi: 10.1007/s11897-012-0101-0. Curr Heart Fail Rep. 2012. PMID: 22798047 Free PMC article. Review.

3

TRP-ing up heart and vessels: canonical transient receptor potential channels and cardiovascular disease.

Rowell J, Koitabashi N, Kass DA. Rowell J, et al. J Cardiovasc Transl Res. 2010 Oct;3(5):516-24. doi: 10.1007/s12265-010-9208-4. Epub 2010 Jul 22. J Cardiovasc Transl Res. 2010. PMID: 20652467 Free PMC article. Review.

4

Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

Tsai EJ, Kass DA. Tsai EJ, et al. Pharmacol Ther. 2009 Jun;122(3):216-38. doi: 10.1016/j.pharmthera.2009.02.009. Epub 2009 Mar 21. Pharmacol Ther. 2009. PMID: 19306895 Free PMC article. Review.

5

Message delivered: how myocytes control cAMP signaling.

Kass DA. Kass DA. Circ Res. 2008 May 9;102(9):1002-4. doi: 10.1161/CIRCRESAHA.108.176420. Circ Res. 2008. PMID: 18467638 Free PMC article. No abstract available.

6

Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload.

Nagayama T, Hsu S, Zhang M, Koitabashi N, Bedja D, Gabrielson KL, Takimoto E, Kass DA. Nagayama T, et al. J Am Coll Cardiol. 2009 Jan 13;53(2):207-15. doi: 10.1016/j.jacc.2008.08.069. J Am Coll Cardiol. 2009. PMID: 19130990 Free PMC article.

7

PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy.

Oeing CU, Nakamura T, Pan S, Mishra S, Dunkerly-Eyring BL, Kokkonen-Simon KM, Lin BL, Chen A, Zhu G, Bedja D, Lee DI, Kass DA, Ranek MJ. Oeing CU, et al. Circ Res. 2020 Jul 31;127(4):522-533. doi: 10.1161/CIRCRESAHA.119.315714. Epub 2020 May 12. Circ Res. 2020. PMID: 32393148 Free PMC article.

8

PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.

Ranek MJ, Kokkonen-Simon KM, Chen A, Dunkerly-Eyring BL, Vera MP, Oeing CU, Patel CH, Nakamura T, Zhu G, Bedja D, Sasaki M, Holewinski RJ, Van Eyk JE, Powell JD, Lee DI, Kass DA. Ranek MJ, et al. Nature. 2019 Feb;566(7743):264-269. doi: 10.1038/s41586-019-0895-y. Epub 2019 Jan 30. Nature. 2019. PMID: 30700906 Free PMC article.

9

Res-erection of Viagra as a heart drug.

Kass DA. Kass DA. Circ Heart Fail. 2011 Jan;4(1):2-4. doi: 10.1161/CIRCHEARTFAILURE.110.960062. Circ Heart Fail. 2011. PMID: 21245454 No abstract available.

10

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.

Lee DI, Zhu G, Sasaki T, Cho GS, Hamdani N, Holewinski R, Jo SH, Danner T, Zhang M, Rainer PP, Bedja D, Kirk JA, Ranek MJ, Dostmann WR, Kwon C, Margulies KB, Van Eyk JE, Paulus WJ, Takimoto E, Kass DA. Lee DI, et al. Nature. 2015 Mar 26;519(7544):472-6. doi: 10.1038/nature14332. Epub 2015 Mar 18. Nature. 2015. PMID: 25799991 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

33 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year